1/14
11:32 am
bio
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $481.00 price target on the stock.
Low
Report
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $481.00 price target on the stock.
1/14
11:32 am
bio
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $481.00 price target on the stock.
Low
Report
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $481.00 price target on the stock.
1/14
11:17 am
bio
Rating for BIO
Low
Report
Rating for BIO
1/14
11:17 am
bio
Rating for BIO
Low
Report
Rating for BIO
12/9
08:47 am
bio
Rating for BIO
Medium
Report
Rating for BIO
12/9
08:47 am
bio
Rating for BIO
Medium
Report
Rating for BIO